Clinical Trial on Alzheimer Disease, Presbycusis and Hearing Aids

Clinical Trial on Cognitive, Behavioural, Quality of Life and Medico-economic Benefits of Hearing Aids in Alzheimer Disease Patients Suffering From Presbycusis

This is a 12-months' randomized clinical trial that aims at studying the benefit of bilateral hearing aids in hearing impaired patients suffering from a slight to moderate stage Alzheimer disease.

The benefit of this intervention will be studied in the cognitive, behavioural, quality of life and economic fields.

2groups are involved in this trial: Intervention group: 12 months' treatment with active hearing aids, fitted hearing impairment Control group: 6 months' treatment with placebo hearing aids, followed with 6 months' active hearing aids, fitted hearing impairment

Inclusion Criteria:

• > 65 year-old
• Medical diagnosis of Alzheimer disease
• 15 ≤ MMSE ≤ 25
• No hearing aids in the last 2 years
• Motivated caregiver living with the patient
• Sensorineural hearing loss

Exclusion Criteria:

• Beginning of an anticholinesterasic treatment in the last 6 months
• Change in the anticholinesterasic treatment in the last 2 months